Protease inhibitors and azolic antifungals in HIV patients with histoplasmosis: a clinical pharmacokinetics perspective

Protease inhibitors and azolic antifungals in HIV patients with histoplasmosis: a clinical pharmacokinetics perspective

Bibliographic Details
Main Author:	Lucas Miyake Okumura
Format:	Article
Language:	English
Published:	Elsevier 2016-07-01
Series:	Brazilian Journal of Infectious Diseases
Online Access:	http://www.sciencedirect.com/science/article/pii/S1413867016300538

Similar Items

The pharmacokinetic properties of HIV-1 protease inhibitors: A computational perspective on herbal phytochemicals
by: Idowu Kehinde, et al.
Published: (2019-10-01)

HIV-Associated Histoplasmosis: Current Perspectives
by: Myint T, et al.
Published: (2020-03-01)

Antifungal Activity and Synergism with Azoles of Polish Propolis
by: Katarzyna Gucwa, et al.
Published: (2018-06-01)

Azole antifungal drugs mode of action and resistance
by: Venkateswarlu, Kanamarlapudi
Published: (1996)

Exposure of candida to an agricultural azole: effects upon the susceptibility profile to clinical antifungals
by: Pedro Filipe Ribeiro Tavares
Published: (2019)

Chloroquine sensitizes biofilms of Candida albicans to antifungal azoles
by: Ravikumar Bapurao Shinde, et al.

Chloroquine sensitizes biofilms of Candida albicans to antifungal azoles
by: Ravikumar Bapurao Shinde, et al.
Published: (2013-07-01)

Antifungal azole metabolites: Significance in pharmaceutical and biomedical analysis
by: Kokil Sachin, et al.
Published: (2009-01-01)

An Aptamer-Based Biosensor for the Azole Class of Antifungal Drugs
by: Gregory R. Wiedman, et al.
Published: (2017-08-01)

Azole antifungal drugs and cytochrome P450 induction
by: Sabzevari, Omid
Published: (1994)

The clinical implications of human immunodeficiency virus-1 protease inhibitor pharmacokinetics
by: Winston, Alan
Published: (2008)

Unexpected effects of azole transporter inhibitors on antifungal susceptibility in Candida glabrata and other pathogenic Candida species.
by: Yohsuke Nagayoshi, et al.
Published: (2017-01-01)

Antifungal agents: Polyene, azole, antimetabolite, other and future agents
by: Fardin Ali Malayeri, et al.
Published: (2018-03-01)

Abnormal Ergosterol Biosynthesis Activates Transcriptional Responses to Antifungal Azoles
by: Chengcheng Hu, et al.
Published: (2018-01-01)

The Effects of Antifungal Azoles on Inflammatory Cytokine Production in Human Keratinocytes
by: K Zomorodian, et al.
Published: (2008-04-01)

Cytochrome P450 inhibition and azole antifungal mode of action
by: Lamb, David Christopher
Published: (1995)

Uniderstanding inter-individual variability in the pharmacokinetics of protease inhibitors
by: Chaikan, Ammara
Published: (2010)

Lumacaftor/ivacaftor initiation in two liver transplantation patients under tacrolimus and antifungal azoles
by: Ikrame Chouchane, et al.
Published: (2019-04-01)

Azole Resistance in Aspergillus fumigatus: A Consequence of Antifungal Use in Agriculture?
by: Sarah Berger, et al.
Published: (2017-06-01)

Mechanism of CYP3A4 inhibition by antifungal azole compounds
by: Sheng-chun Kuo, et al.
Published: (2008)

An Investigation of Antifungal Photodynamic Therapy Against Azole-resistant Candida Species
by: CHUANG, WEN-CHING, et al.
Published: (2017)

Antifungal Activity of Minocycline and Azoles Against Fluconazole-Resistant Candida Species
by: Jingwen Tan, et al.
Published: (2021-05-01)

Review of Pharmacologic Considerations in the Use of Azole Antifungals in Lung Transplant Recipients
by: Megan E. Klatt, et al.
Published: (2021-01-01)

Clinicomycological Profile and Antifungal Sensitivity Pattern of Commonly Used Azoles in Dermatophytosis
by: Mahesh Mathur, et al.
Published: (2015-06-01)

Detecting Azole-Antifungal Resistance in <i>Aspergillus fumigatus</i> by Pyrosequencing
by: Mireille H. van der Torre, et al.
Published: (2020-01-01)

Triazole derivatives with improved in vitro antifungal activity over azole drugs
by: Yu S, et al.
Published: (2014-04-01)

Clinicomycological Profile and Antifungal Sensitivity Pattern of Commonly Used Azoles in Dermatophytosis
by: Mahesh Mathur, et al.
Published: (2015-06-01)

Studies on azole resistance and virulence of Candida albicans, and novel antifungal agents
by: Kamai, Yasuki
Published: (2011)

In vitro activity of the antifungal azoles itraconazole and posaconazole against Leishmania amazonensis.
by: Sara Teixeira de Macedo-Silva, et al.
Published: (2013-01-01)

Susceptibility of Susceptibility of Susceptibility of Candida Candida spp. Oral isolates for azolic spp. Oral isolates for azolic antifungals and amphotericin B
by: Vivian Fernandes Furlletti, et al.
Published: (2016-01-01)

Requirement for ergosterol in V-ATPase function underlies antifungal activity of azole drugs.
by: Yong-Qiang Zhang, et al.
Published: (2010-06-01)

Mini review: interactions between antifungal azoles, neurological bladder and urinary problems
by: Nadia Bounoua, et al.
Published: (2019-12-01)

Interaction of azole antifungal agents with mouse hepatic microsomal cytochromes P-450
by: Ballard, S. A.
Published: (1988)

Synthesis of HIV protease inhibitors
by: Lee, Victor
Published: (1991)

Antifungal activity of terrestrial Streptomyces rochei strain HF391 against clinical azole -resistant Aspergillus fumigatus
by: S Hadizadeh, et al.
Published: (2015-03-01)

CORRELATE BETWEEN BIOFILM FORMATION AND AZOLE ANTIFUNGAL SUSCEPTIBILITY AGAINST PLANKTONIC AND SESSILE CANDIDA ALBICANS CLINICAL ISOLATES
by: Saira Salim, et al.
Published: (2021-06-01)

Oral Histoplasmosis in A HIV Patient - A Case Report
by: Karthikeya Patil, et al.
Published: (2003-01-01)

Pre-Clinical and Clinical Investigation of Pharmacokinetic and Pharmacodynamic Interactions between Darunavir, a Novel Protease Inhibitor and Rosuvastatin
by: Samineni, Divya
Published: (2011)

Pharmacokinetic and metabolic effects of American ginseng (<it>Panax quinquefolius</it>) in healthy volunteers receiving the HIV protease inhibitor indinavir
by: Flexner Charles W, et al.
Published: (2008-08-01)

Disseminated Histoplasmosis in HIV-Infected Patients: A Description of 34 Years of Clinical and Therapeutic Practice
by: Mathieu Nacher, et al.
Published: (2020-09-01)